World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
56199
World Ranking
8418
National Ranking
4352

Michael A. Weber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael A. Weber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 656 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael A. Weber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. Weber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael A. Weber is affiliated with SUNY Downstate Medical Center in the United States and has contributed extensively to medical research, focusing primarily on cardiology and cardiovascular medicine.

Their research output includes a strong emphasis on hypertension and cardiovascular health, reflected in numerous publications and participation in clinical trials. Recent notable papers authored by or involving related research include:

  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial, 2020, The Lancet
  • Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial, 2021, The Lancet
  • Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial, 2022, The Lancet
  • Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial, 2022, The Lancet
  • Hypertension management in patients with cardiovascular comorbidities, 2022, European Heart Journal

The scientist frequently collaborates with several other researchers in the field. Key co-authors include:

  • Felix Mahfoud
  • Roland E. Schmieder
  • David E. Kandzari
  • Kazuomi Kario
  • Michael Böhm

Michael A. Weber has published extensively in specialized journals related to hypertension and cardiovascular interventions. The most frequent publication venues are:

  • Journal of Hypertension
  • Hypertension
  • Journal of Clinical Hypertension
  • JACC: Cardiovascular Interventions
  • Journal of Human Hypertension

Their main field of study is medicine, with significant research concentrated within cardiology and cardiovascular medicine. Additional subfields encompass surgery, nutrition and dietetics, endocrinology, diabetes and metabolism, as well as psychiatry and mental health.

Research topics covered by their work include:

  • Blood Pressure and Hypertension Studies
  • Sodium Intake and Health
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Health and Disease Prevention
  • Hemodynamic Monitoring and Therapy
  • Cardiovascular Syncope and Autonomic Disorders
  • Hormonal Regulation and Hypertension

Best Publications

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

    Stevo Julius;Sverre E Kjeldsen;Michael Weber;Hans R Brunner

  • Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension

    Michael A. Weber;Ernesto L. Schiffrin;William B. White;Samuel Mann

  • Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients

    Kenneth Jamerson;Michael A. Weber;George L. Bakris;Björn Dahlöf

  • Hemodynamic Patterns of Age-Related Changes in Blood Pressure: The Framingham Heart Study

    Stanley S. Franklin;William Gustin;Nathan D. Wong;Martin G. Larson

  • Beta-adrenergic activation and memory for emotional events.

    Larry Cahill;Bruce Prins;Michael Weber;Michael Weber;James L. McGaugh

  • Feasibility of Treating Prehypertension with an Angiotensin-Receptor Blocker

    Stevo Julius;Shawna D. Nesbitt;Brent M. Egan;Michael A. Weber

  • Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

    Ralph L. Sacco;Hans-Christoph Diener;Salim Yusuf;Daniel Cotton

  • Telmisartan to prevent recurrent stroke and cardiovascular events.

    Salim Yusuf;Salim Yusuf;Hans-Christoph Diener;Ralph L. Sacco;Daniel Cotton

  • Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

    Deepak L. Bhatt;Marcus D. Flather;Werner Hacke;Peter B. Berger

  • Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

    Henry R. Black;William J. Elliott;Gregory Grandits;Patricia Grambsch

  • Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

    Michael A Weber;Stevo Julius;Sverre E Kjeldsen;Hans R Brunner

  • Critical issues in peripheral arterial disease detection and management: a call to action.

    Jill J. F. Belch;Eric J. Topol;Giancarlo Agnelli;Michel Bertrand

  • Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial

    David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend

  • Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial

    Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario

  • Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

    Michel Azizi;Michel Azizi;Roland E Schmieder;Felix Mahfoud;Felix Mahfoud;Michael A Weber

  • Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

    George L. Bakris;Pantelis A. Sarafidis;Matthew R. Weir;Björn Dahlöf

  • Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial

    Michael Böhm;Kazuomi Kario;David E. Kandzari;Felix Mahfoud;Felix Mahfoud

  • The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data

    Victor J. Dzau;Kenneth Bernstein;David Celermajer;Jerome Cohen;Jerome Cohen

  • Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

    Hans-Christoph Diener;Ralph L Sacco;Salim Yusuf;Daniel Cotton

Frequent Co-Authors

Nanette K. Wenger
Nanette K. Wenger Emory University
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
George L. Bakris
George L. Bakris University of Chicago
John H. Laragh
John H. Laragh Cornell University
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Giuseppe Mancia
Giuseppe Mancia University of Milano-Bicocca
Alberto Zanchetti
Alberto Zanchetti University of Milan
Henry R. Black
Henry R. Black New York University School of Medicine
William B. White
William B. White University of Connecticut
Ellis R. Levin
Ellis R. Levin University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees is a smart way to start or advance a career in the healthcare sector if you’re considering Medicine in the USA. Many students pursue healthcare administration programs online. These flexible pathways prepare graduates for essential roles in hospital operations and policy-making.

Nursing professionals looking to expand their clinical scope might consider specialized adn to fnp bridge programs. These programs are designed for registered nurses with an associate’s degree, providing a streamlined route to becoming a Family Nurse Practitioner.

For those interested in public health, dietetics, or wellness, an online nutrition degree offers a foundation in both science and patient care fields. This is ideal for students wanting to integrate nutritional science into clinical or community careers.

Accreditation is crucial for ensuring quality education. For those seeking leadership roles in healthcare, it’s important to look for which online healthcare administration programs have cahme accreditation? Programs with this credential offer industry-recognized standards and improve professional credibility.

Best Scientists Citing Michael A. Weber

Trending Scientists

Recently Published Articles